Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DarioHealth Corp.DRIO · Entity 7024 | Director | September 24, 2026 | September 28, 2026 |
| Lucid Diagnostics Inc.LUCD · Entity 6375 | Director | February 20, 2026 | February 24, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DarioHealth Corp.
Report date September 24, 2026 · Filed September 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 66,500 |
Reported balance
After 2026-09-24 transaction · row 1
1 source rowRow 1 · 2026-09-24 · Grant · Acquired 62,000 · Balance 66,500 F1: The restricted share award shall vest on the second anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted share award shall vest on the second anniversary of the grant date.
Lucid Diagnostics Inc.
Report date February 20, 2026 · Filed February 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 338,000 |
Reported balance
After 2026-02-20 transaction · row 1
1 source rowRow 1 · 2026-02-20 · Grant · Acquired 123,000 · Balance 338,000 F1: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 24, 2026 Filed Sep 28, 2026 20:07 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon stock | 62,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-111353 · tm2626098-4_4seq1.xml · nonDerivative · entry 1 PALUMBO JOHN R · CIK 0001251475 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,500 F1 · date: The restricted share award shall vest on the second anniversary of the grant date. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 23:47 UTC | Lucid Diagnostics Inc. LUCD · Entity 6375 | GrantCommon Stock | 123,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001094891-26-000073 · form4.xml · nonDerivative · entry 1 PALUMBO JOHN R · CIK 0001251475 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 338,000 F1 · shares: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed. Read SEC document |
| October 06, 2025 Filed Oct 7, 2025 20:46 UTC | Lucid Diagnostics Inc. LUCD · Entity 6375 | GrantEmployee stock option (right to buy) · Derivative | 215,000 | $0.00 Strike: $1.03 | $0.00 |
DisclosureSEC source: 0001094891-25-000050 · form4.xml · derivative · entry 1 PALUMBO JOHN R · CIK 0001251475 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 215,000 Underlying: Common Stock · 215,000 shares Expires 2035-10-06 F1 · derivative.exercise_date: The option was granted pursuant to the issuer's Amended and Restated 2018 Long-Term Incentive Equity Plan. One third of the option vests on June 30, 2026 and the balance vests in eight equal quarterly installments, starting September 30, 2026 and ending on June 30, 2028. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.